[Prevention and treatment of hepatitis B virus infection after liver transplantation].
Roche
Bruno
B
Centre Hépatobiliaire, EA 3541, Université Paris-Sud, Villejuif, France.
Samuel
Didier
D
D000998:Antiviral Agents / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission*; D006515:Hepatitis B virus / Q000472:pathogenicity*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects*; D013534:Survival
D000998:Antiviral Agents; D019259:Lamivudine